高齢者医療とは
関連する実験動画
Updated: Nov 9, 2026

03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
1Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.
JAMA
|June 1, 1994
まとめ
高齢者の障害を予防するには,教育とカウンセリングを通じて,若い成人のライフスタイルの選択に焦点を当てることが必要です. 更年期後のエストロゲン療法の長期的な効果については,さらなる研究が必要である.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 予防医学は,予防的な医療です.
- 公衆衛生は公衆衛生である.
背景:
- 高齢者の障害は,公衆衛生上の大きな課題となっています.
- 現在の介入は,予防ではなく,既存の状態の管理に焦点を当てていることが多い.
- 若い成人期に確立されたライフスタイルの要因は,長期的な健康結果に大きく影響を与えます.
研究 の 目的:
- 高齢者の将来の障害を軽減する上で,早期のライフスタイル介入の重要な役割を強調する.
- 一般の人々および個人における健康慣行に影響を与えるための効果的な戦略を探求する.
- 閉経後のエストロゲン療法の最適な期間に関する不確実性を解決するために.
主な方法:
- ライフスタイル要因と老化に関する既存の文献のレビュー.
- 教育プログラムが人口の健康行動に及ぼす影響の分析.
- 健康行動修正のための個々のカウンセリングアプローチの検討.
- エストロゲン療法期間に関する現在の証拠の議論.
主要な成果:
- 若き成人期におけるライフスタイルの選択は,後年における障害レベルと強く相関しています.
- 保健教育プログラムと個人カウンセリングは,医療慣行に影響を与える可能性を示しています.
- 閉経後の女性のエストロゲン治療の最適な持続時間に関する証拠は不確実です.
結論:
- 医師の焦点は,高齢者の障害を軽減するために,若い成人の健康的なライフスタイルを促進する方向に転換する必要があります.
- 健康行動の変化には,集団レベルの教育と個人カウンセリングの組み合わせが推奨されます.
- 更年期後のエストロゲン療法の最適な期間とリスク/利益を決定するために,さらなる研究が必要である.
関連する概念動画
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...